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Background: There is accumulating evidence that, compared to conventional surgery with left internal thoracic artery to Left anterior descending 
(LITA-LAD) graft, multi-arterial CABG leads to improved survival. We aimed to investigate whether extending arterial grafting to 3 or more provides an 
incremental advantage.
methods: We analyzed late CABG mortality data in 11,931 patients [64.3±10.5yrs; 29.2% women (29.2%); 36% diabetic] derived from 4 US 
institutions (3 OH, 1 NY; 1994-2011) that underwent primary isolated CABG with one or more arterial grafts: 1-artery (N=6782; 56.9%); 2-artery 
(N=3678; 30.8%) and 3-artery (N=1471; 12.3%). Radial artery (94%) and RITA (6%) grafts were used. Propensity score matching was used for risk 
adjustment with Kaplan-Meier comparisons.
results: Multiple arterial grafts were associated with significantly better 16-year survival advantage compared to traditional CABG with 
incrementally lower hazard ratios: 2 vs 1 artery [HR (95% C.I.)=0.83 (0.76-0.92)] and 3 vs 1 artery [HR= 0.80 (0.69-0.94)]. The 3 vs 2 comparison 
was consistent even if not significant [HR=0.84 (0.79-1.12)]. Importantly, these results were generally similar in both the diabetic and non-diabetic 
sub-cohorts, and showed comparable incremental benefit in diabetics and non-diabetics.[Fig]
conclusions: Our data support the use of two or more arterial grafts for multivessel CABG irrespective of diabetes status.
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